Inhibition of α-glucosidase activity and intestinal glucose transport to assess the in vivo anti-hyperglycemic potential of dodecyl-acylated phlorizin and polydatin derivatives

Dodecyl phlorizin and polydatin derivatives are safe and promising in vivo hypoglycemic active compounds that can inhibit the hydrolytic activity of α-glucosidase and intestinal glucose absorption.